DNA released from dying host cells mediates aluminum adjuvant activity T Marichal, K Ohata, D Bedoret, C Mesnil, C Sabatel, K Kobiyama, ... Nature medicine 17 (8), 996-1002, 2011 | 614 | 2011 |
Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms E Kuroda, KJ Ishii, S Uematsu, K Ohata, C Coban, S Akira, K Aritake, ... Immunity 34 (4), 514-526, 2011 | 230 | 2011 |
Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9 C Coban, Y Igari, M Yagi, T Reimer, S Koyama, T Aoshi, K Ohata, ... Cell host & microbe 7 (1), 50-61, 2010 | 220 | 2010 |
TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN B Temizoz, E Kuroda, K Ohata, N Jounai, K Ozasa, K Kobiyama, T Aoshi, ... European journal of immunology 45 (4), 1159-1169, 2015 | 134 | 2015 |
Inhaled fine particles induce alveolar macrophage death and interleukin-1α release to promote inducible bronchus-associated lymphoid tissue formation E Kuroda, K Ozasa, B Temizoz, K Ohata, CX Koo, T Kanuma, T Kusakabe, ... Immunity 45 (6), 1299-1310, 2016 | 124 | 2016 |
Hydroxypropyl-β-cyclodextrin spikes local inflammation that induces Th2 cell and T follicular helper cell responses to the coadministered antigen M Onishi, K Ozasa, K Kobiyama, K Ohata, M Kitano, K Taniguchi, ... The Journal of Immunology 194 (6), 2673-2682, 2015 | 71 | 2015 |
Lipocalin 2 bolsters innate and adaptive immune responses to blood-stage malaria infection by reinforcing host iron metabolism H Zhao, A Konishi, Y Fujita, M Yagi, K Ohata, T Aoshi, S Itagaki, S Sato, ... Cell host & microbe 12 (5), 705-716, 2012 | 65 | 2012 |
The malarial metabolite hemozoin and its potential use as a vaccine adjuvant C Coban, M Yagi, K Ohata, Y Igari, T Tsukui, T Horii, KJ Ishii, S Akira Allergology International 59 (2), 115-124, 2010 | 62 | 2010 |
The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant CK Tang, T Aoshi, N Jounai, J Ito, K Ohata, K Kobiyama, BH Dessailly, ... PloS one 8 (3), e60038, 2013 | 40 | 2013 |
Serum Liver‐Type Fatty Acid–Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma A Eguchi, H Hasegawa, M Iwasa, Y Tamai, K Ohata, T Oikawa, T Sugaya, ... Hepatology Communications 3 (6), 825-837, 2019 | 23 | 2019 |
Utility of urinary tubular markers for monitoring chronic tubulointerstitial injury after ischemia–reperfusion D Ichikawa, A Kamijo‐Ikemori, T Sugaya, K Ohata, M Hisamichi, ... Nephrology 23 (4), 308-316, 2018 | 21 | 2018 |
Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats S Yamada, J Tanabe, Y Ogura, Y Nagai, T Sugaya, K Ohata, Y Natsuki, ... Clinical and Experimental Nephrology, 1-11, 2021 | 20 | 2021 |
Urinary level of liver-type fatty acid binding protein reflects the degree of tubulointerstitial damage in polycystic kidney disease S Watanabe, D Ichikawa, T Sugaya, K Ohata, K Inoue, S Hoshino, ... Kidney and Blood Pressure Research 43 (6), 1716-1729, 2018 | 16 | 2018 |
Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1a receptor expression K Ohata, A Kamijo-Ikemori, T Sugaya, C Hibi, T Nakamura, T Murase, ... European Journal of Pharmacology 815, 88-97, 2017 | 16 | 2017 |
The possibility of urinary liver-type fatty acid-binding protein as a biomarker of renal hypoxia in spontaneously diabetic torii fatty rats J Tanabe, Y Ogura, M Nakabayashi, Y Nagai, S Watanabe, T Sugaya, ... Kidney and Blood Pressure Research 44 (6), 1476-1492, 2019 | 14 | 2019 |
Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats S Yamada, Y Ogura, K Inoue, J Tanabe, T Sugaya, K Ohata, Y Nagai, ... Molecular and Cellular Endocrinology 539, 111472, 2022 | 10 | 2022 |
Renoprotective effects of voluntary running exercise training on aldosterone-induced renal injury in human L-FABP chromosomal transgenic mice K Kosaki, T Sugaya, K Ohata, J Tanabe, S Hoshino, K Inoue, K Kimura, ... Hypertension Research 42 (10), 1518-1527, 2019 | 10 | 2019 |
Temporal changes in urinary excretion of liver-type fatty acid binding protein (L-FABP) in acute kidney injury model of domestic cats: a preliminary study M Katayama, T Miyazaki, K Ohata, T Oikawa, J Kamiie, T Sugaya, ... Journal of Veterinary Medical Science 81 (12), 1868-1872, 2019 | 10 | 2019 |
Renal expression and urinary excretion of liver‐type fatty acid‐binding protein in cats with renal disease M Katayama, K Ohata, T Miyazaki, R Katayama, N Wakamatsu, M Ohno, ... Journal of veterinary internal medicine 34 (2), 761-769, 2020 | 8 | 2020 |
Relationship between urinary liver-type fatty acid-binding protein (L-FABP) and sarcopenia in spontaneously diabetic torii fatty rats J Tanabe, Y Ogura, K Kosaki, Y Nagai, T Sugaya, K Ohata, S Watanabe, ... Journal of diabetes research 2020, 2020 | 8 | 2020 |